{"id":"https://openalex.org/W1995364352","doi":"https://doi.org/10.1097/00007691-200010000-00006","title":"Pharmacokinetics and Safety of Single Oral Doses of Sirolimus (Rapamycin) in Healthy Male Volunteers","display_name":"Pharmacokinetics and Safety of Single Oral Doses of Sirolimus (Rapamycin) in Healthy Male Volunteers","alternate_titles":[],"publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W1995364352","doi":"https://doi.org/10.1097/00007691-200010000-00006","mag":"1995364352","pmid":"https://pubmed.ncbi.nlm.nih.gov/11034258"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-200010000-00006","doi":"https://doi.org/10.1097/00007691-200010000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200010000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995364352"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5096864031","display_name":"Christina Brattstr m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christina Brattstr??m","raw_affiliation_strings":["Division of Transplantation Surgery, Department of Surgery and Division of \u2020Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology at Karolinska Institute, Huddinge Hospital, Huddinge, \u2021Quintiles AB, Phase I Services, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Transplantation Surgery, Department of Surgery and Division of \u2020Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology at Karolinska Institute, Huddinge Hospital, Huddinge, \u2021Quintiles AB, Phase I Services, Uppsala, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108219847","display_name":"Juliette S we","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juliette S??we","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028714226","display_name":"B. Jansson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bertil Jansson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109982212","display_name":"Anna L nnebo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna L??nnebo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110071028","display_name":"Jan Nordin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan Nordin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108509033","display_name":"James J. Zimmerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James J. Zimmerman","raw_affiliation_strings":["Clin Pharmacokinet Department, Wyeth-Ayerst Research, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clin Pharmacokinet Department, Wyeth-Ayerst Research, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111878829","display_name":"James T. Burke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James T. Burke","raw_affiliation_strings":["Clinical Research and Development, Wyeth-Ayerst Research, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research and Development, Wyeth-Ayerst Research, Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111601127","display_name":"CARL GUSTAV GROTH","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carl G. Groth","raw_affiliation_strings":["Division of Transplantation Surgery, Department of Surgery and Division of \u2020Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology at Karolinska Institute, Huddinge Hospital, Huddinge, \u2021Quintiles AB, Phase I Services, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Transplantation Surgery, Department of Surgery and Division of \u2020Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology at Karolinska Institute, Huddinge Hospital, Huddinge, \u2021Quintiles AB, Phase I Services, Uppsala, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111601127"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":0.8494,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.71386946,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"22","issue":"5","first_page":"537","last_page":"544"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.07599999755620956,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.04410000145435333,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5410000085830688},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8149999976158142},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7390000224113464},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7260000109672546},{"id":"https://openalex.org/keywords/terminal-half-life","display_name":"terminal half-life","score":0.597000002861023},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.7549999952316284},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7730000019073486},{"id":"https://openalex.org/keywords/asthenia","display_name":"asthenia","score":0.9399999976158142}],"concepts":[{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.8830165863037109},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7938487529754639},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7037107348442078},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6799095273017883},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6594122052192688},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6467701196670532},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48858770728111267},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4799061715602875},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.46356281638145447},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.44672098755836487},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.43928784132003784},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.42381080985069275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3838638961315155},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-200010000-00006","doi":"https://doi.org/10.1097/00007691-200010000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200010000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:11034258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11034258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W203560874","https://openalex.org/W273792271","https://openalex.org/W1964662082","https://openalex.org/W1975039776","https://openalex.org/W1998150584","https://openalex.org/W2011010559","https://openalex.org/W2015407598","https://openalex.org/W2042954145","https://openalex.org/W2045224469","https://openalex.org/W2050621654","https://openalex.org/W2080425667","https://openalex.org/W2093979198","https://openalex.org/W2115072188","https://openalex.org/W2415680990"],"related_works":["https://openalex.org/W1964662082","https://openalex.org/W2000844233","https://openalex.org/W81421712","https://openalex.org/W2945076194","https://openalex.org/W645093488","https://openalex.org/W2080425667","https://openalex.org/W2112057273","https://openalex.org/W2083432784","https://openalex.org/W2075421237","https://openalex.org/W1976350400"],"abstract_inverted_index":{"A":[0],"phase":[1],"I":[2,56],"study":[3],"was":[4,115,207],"conducted":[5],"to":[6,38,223],"determine":[7],"the":[8,82,86,100,110,116,128,138,157],"pharmacokinetics,":[9],"safety,":[10],"and":[11,25,71,103,154,178,194],"tolerability":[12],"of":[13,28,43,85,95,105,124,134,180,201,215,220],"sirolimus,":[14],"a":[15,210],"new":[16],"immunosuppressive":[17],"drug,":[18],"in":[19,32,54,99,109,122,127,137,147,230],"45":[20,87],"healthy":[21,231],"men":[22],"between":[23],"19":[24,94],"36":[26],"years":[27],"age.":[29],"Nine":[30],"subjects":[31],"each":[33],"group":[34,55,59,63,67,72,102,112,130,140],"were":[35,98,108,183,227],"randomly":[36],"assigned":[37],"receive":[39],"single":[40],"oral":[41,174,218],"doses":[42,219],"either":[44],"sirolimus":[45,101,129,202,221],"(n":[46,51],"=":[47,52],"6)":[48],"or":[49],"placebo":[50,111,139],"3)":[53],"(0.3":[57,222],"mg/m2),":[58,62,66],"II":[60],"(1":[61],"III":[64],"(3":[65],"IV":[68],"(5":[69],"mg/m2)":[70,225],"V":[73],"(8":[74],"mg/m2).":[75],"No":[76],"serious":[77],"adverse":[78,92,119],"events":[79],"occurred":[80,143],"during":[81],"study.":[83],"Twenty-eight":[84],"volunteers":[88],"(62%)":[89],"reported":[90],"an":[91],"event;":[93],"30":[96,125],"(63%)":[97],"9":[104],"15":[106,135],"(60%)":[107],"(ns).":[113,141],"Asthenia":[114],"most":[117],"common":[118],"event,":[120],"occurring":[121],"7":[123],"(23%)":[126],"compared":[131],"with":[132,162,209],"6":[133],"(40%)":[136],"Absorption":[142],"within":[144],"1":[145],"hour":[146],"all":[148],"volunteers.":[149,233],"Whole":[150],"blood":[151,168,205],"peak":[152],"concentration":[153],"area":[155],"under":[156],"concentration-time":[158],"curve":[159],"increased":[160],"proportionally":[161],"dose.":[163],"Mean":[164],"(+/-":[165],"SD)":[166],"whole":[167,212],"terminal":[169],"disposition":[170],"half-life":[171],"(t1/2),":[172],"apparent":[173],"dose":[175],"clearance":[176],"(Cl/F),":[177],"volume":[179],"distribution":[181],"(Vss/F)":[182],"82":[184],"+/-":[185,189,196],"12":[186],"hours,":[187],"278":[188],"117":[190],"mL/h":[191],"x":[192],"kg":[193],"23":[195],"10":[197],"L/kg,":[198],"respectively.":[199],"Distribution":[200],"into":[203],"formed":[204],"elements":[206],"extensive,":[208],"mean":[211],"blood-to-plasma":[213],"ratio":[214],"36.":[216],"Single":[217],"8":[224],"solution":[226],"well":[228],"tolerated":[229],"male":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995364352","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
